Skip to search formSkip to main contentSkip to account menu

Halcion

Known as: Pfizer Brand of Triazolam, Triazolam Pfizer Brand 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
OBJECTIVES An acceleration of the wound healing process expedites chronic wound patient's return to normal social environments… 
2009
2009
volume 27 number 4 april 2009 nature biotechnology hybrid between academia and industry, bringing the scientific rigor and… 
2002
2002
When assessing the risks and benefits of medical drugs, the approach may be precautionary or permissive. If these different… 
Review
2001
Review
2001
This paper uses the case study of the crisis surrounding the benzodiazepine sleeping tablet Halcion (triazolam), particularly in… 
1989
1989
: In the course of 1979 the Netherlands Centre for Monitoring of Adverse Reactions to Drugs (NARD) received a remarkably large… 
1983
1983
Triazolam is a sedative/hypnotic triazolo-benzodiazepine, structurally related to alprazolam. Recently, it has been approved for… 
1981
1981
In a double‐blind, cross‐over trial, triazolam (0.25 mg) was tested against flunitrazepam (1 mg) in the typical midwinter… 
1980
1980
The hypnotic effects of triazolam (Halcion) 0.25 mg and flunitrazepam (Rohypnol) 2 mg were compared in a randomized double-blind… 
1978
1978
In this multi-clinic double-blind study, patients suffering from insomnia were treated with triazolam 0.5 mg (Halcion) or placebo…